PTEN and cancer: There were significant associations between PTEN loss and Gleason score (P<0.001), clinical stage (P<0.001), baseline PSA (P<0.001) and cancer in biopsy (proportion of TURP chips with disease or linear proportion of needle biopsy containing disease) (P<0.001), but no association with age (Table 1).